![Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG | Leukemia Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2013.297/MediaObjects/41375_2014_Article_BFleu2013297_Fig1_HTML.jpg)
Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG | Leukemia
![Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fd63eb214ea90b377cbaa2b0d0bda2b9548b23ae/7-Figure3-1.png)
Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar
![Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression](https://www.spandidos-publications.com/article_images/etm/14/2/etm-14-02-1081-g01.jpg)
Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression
![Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/0d9a6ccd-b391-44ac-94b2-74651438f447/emmm201910419-abs-0001-m.jpg)
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine
![Chemotherapeutic Agents. Introduction n Classification of Drugs n Cell-cycle specificity n Mechanism of Action n Indication n Side effects. - ppt download Chemotherapeutic Agents. Introduction n Classification of Drugs n Cell-cycle specificity n Mechanism of Action n Indication n Side effects. - ppt download](https://images.slideplayer.com/12/3354361/slides/slide_4.jpg)
Chemotherapeutic Agents. Introduction n Classification of Drugs n Cell-cycle specificity n Mechanism of Action n Indication n Side effects. - ppt download
![Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner - Experimental Hematology Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner - Experimental Hematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6cdbc294-34aa-472d-8f49-bf7904daaf0f/gr1a.jpg)
Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner - Experimental Hematology
![Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy | Journal of Experimental & Clinical Cancer Research | Full Text Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-018-0756-9/MediaObjects/13046_2018_756_Fig2_HTML.gif)
Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
![Acute myeloid leukemia—Major progress over four decades and glimpses into the future - Kantarjian - 2016 - American Journal of Hematology - Wiley Online Library Acute myeloid leukemia—Major progress over four decades and glimpses into the future - Kantarjian - 2016 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1aea9d1a-3773-4672-951c-39a15e7752bd/ajh24246-fig-0001-m.jpg)
Acute myeloid leukemia—Major progress over four decades and glimpses into the future - Kantarjian - 2016 - American Journal of Hematology - Wiley Online Library
![Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML](https://www.mdpi.com/cancers/cancers-13-00966/article_deploy/html/images/cancers-13-00966-g001.png)
Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML
![GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia | Cell Death & Disease GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-021-03504-2/MediaObjects/41419_2021_3504_Fig1_HTML.png)